Leebang @RSNA 2022, open the multi-layout of smart ultrasound!

Recently, the largest medical event in the global radiology community, the North American Radiology Annual Meeting RSNA 2022, was held in Chicago, USA, where radiologists, medical professionals and industry scholars from all over the world gathered to exchange and discuss the latest scientific research results and cutting-edge technologies
in the field of international radiology.
On this grand occasion, Lee Bang once again set sail and brought a number of innovative smart ultrasound solutions to the world stage, using artificial intelligence technology to innovate to create a new highland of smart imaging, empowering diversified medical scenarios, and once again becoming the focus
of attention in the industry.

Smart ultrasound innovation reaches the pinnacle

Close integration with international cutting-edge technology

The core members of Leebang's ultrasound imaging R&D team are all from the world's cutting-edge benchmarking enterprises, high-precision technology is closely integrated with international standards, and its unique Acclarix ultrasound platform is a new generation of ultrasound platform
jointly designed by Leebang's R&D team in the United States and China.
At this exhibition, ultrasound's flagship Acclarix LX9 cart-type all-digital color ultrasound system made its debut in the United States, standing out
for innovative achievements from around the world.

Qiming uses wisdom to become a shadow in the core

Acclarix LX9 cart-style all-digital color ultrasound diagnostic system

The standardization, informatization and intelligence of ultrasound technology will be the trend
of future development.
In recent years, Leebang has continuously invested and made major breakthroughs in the field of medical artificial intelligence, and has achieved a quantitative and standardized ultrasound diagnosis process
by adopting cutting-edge artificial intelligence technology and combining the clinical experience and knowledge of experts.
Lipon's full-stack intelligent medical ultrasound takes the lead in realizing the quantification, automation and intelligence of standard section and biological parameter measurement in multiple intelligent fields such as assisted reproduction, prenatal screening, neonatal hip joint, pelvic floor screening and cardiac assessment, which will provide an important direction
for ultrasound AI technology.

Ultrasound imaging is one of the disciplines that relies heavily on operator techniques and clinical experience, and it is also one of the
biggest problems faced by primary ultrasound.
The ultimate way for more people to truly share the achievements of medical innovation and enable primary medical care to truly solve the "ultrasound problem" is still to achieve medical accessibility and inclusiveness
through the realization of medical artificial intelligence and medical informatization.

In the field of ultrasound artificial intelligence, Leebang has developed a series of products in maternal and child health, vascular access and cardiac function evaluation kit eLV, etc.
, in the face of cumbersome measurement, uneven level, subjective diagnosis, many models, different quality, quality lag and other pain points, Lipon LX9 has realized intelligent application scenarios of intelligent measurement, intelligent scanning and intelligent imaging, automatically measuring the size, area and volume of the target structure, simulating the sonographer's technique, and automatically obtaining ultrasound section and scoring; It reduces the difficulty of imaging, obtains standard diagnostic sections, and provides auxiliary diagnosis to improve diagnostic accuracy and reduce human error
.
In the future, it will continue to cultivate the ultrasound AI market and become an important force
in the field of medical ultrasound.

At the exhibition, Lee Bon also exhibited two equally innovative ultrasound "sharp tools", focusing on cutting-edge technologies close to clinical applications - the Acclarix LX3 cart-type all-digital color ultrasound system and the Acclarix AX3 portable all-digital color ultrasound system
.

Beautiful images both inside and out

Acclarix LX3 cart-type all-digital color ultrasound diagnostic system

The Acclarix LX3 is a new generation ultrasound platform
with independent intellectual property.
In order to meet the challenges of complex ultrasound environment, the R&D team has made every effort to create this all-digital color ultrasound diagnostic system that integrates lightweight body, innovative technology, and intelligent workflow, which has important value
in early screening and diagnosis with excellent machine performance and excellent image quality.
Fully activated 5-probe slots, rich probe groups, self-service teaching software, a variety of imaging technologies, excellent image quality, simple workflow, etc.
, greatly improve the work efficiency of doctors and are favored
by clinicians.

Portable dual plug-in Zhixing world

Acclarix AX3 portable all-digital color ultrasound diagnostic system

AX3 is a lightweight and flexible dual-probe socket notebook color Doppler ultrasound diagnostic system, which gathers light, dual, fast, stable and other characteristics, magnesium aluminum alloy casts a thin and light texture, providing users with a truly portable experience
.
It adopts advanced parallel computing engine and image processing technology, integrates excellent ergonomic design, creates clear images, has sensitive blood flow detection capabilities and extensive probe adaptation capabilities, which can not only meet the needs of routine examination of abdomen, obstetrics and gynecology, heart, small organs, superficial blood vessels, musculoskeletal and other examinations, but also meet the clinical diagnosis needs
of other specialized clinics.

Create a global localized closed-loop ecological chain

The ultrasound business continues to grow rapidly

As an "old friend" of RSNA, Lee Bon has shown the world the latest technological breakthroughs and innovative achievements of Lipon Ultrasound, which on the other hand reflects the hard power
of Lee Bon's global localization.

"Taking clinical and customer needs as the core and laying out a global localized closed-loop ecological chain" is the core
of Leebang's strategy from Shenzhen to the world.
At present, the products are exported to more than 170 countries and regions around the world, with a market penetration rate of more than 85%, representing a shining business card of medical devices in Shenzhen, China, and conveying the strongest voice
of China's independent innovation key technologies to the world.

Leebang's forward-looking strategic approach is inseparable from the layout of overseas markets: on the one hand, it focuses on product research and development and pursues high-quality innovation
.
For the internationalization of Chinese enterprises, it means to achieve localization in various countries, facing the laws and regulations of various countries and the competition against the world's leading brands; On the other hand, create a localized after-sales service experience, strengthen localized promotion, and create a closed-loop ecological chain
integrating production, sales and service.
With excellent product quality, strong sales layout network and localization advantages at home and abroad, Leebang products have gradually flourished
in the European and American sales markets with high entry thresholds.

Last year, Lee Bon started by strengthening strategic planning and organizational capabilities, and cultivated a large number of compound management talents; In view of the business model and global layout, a series of strategic plans have been carried out, and it is planned to complete 3 new overseas subsidiaries in Kenya, Peru and Thailand this year, and the number of overseas sales subsidiaries will reach 8, and Kenya and Thailand have completed registration
.
This has further enhanced Leebang's influence in the global market and laid the foundation
for Leebang to deepen its global market.

According to Lipon's 2021 annual report, its ultrasound imaging business achieved an operating income of 183.
2152 million yuan, a year-on-year increase of 40.
10%; The annual report for the first half of 2022 disclosed that Lipon's ultrasound imaging business increased by more than 30% year-on-year, and it is expected to maintain rapid growth
.

It is reported that Leebang will continue to maintain R&D investment in ultrasound imaging business, continue to seek innovation in intelligent imaging and solve clinical pain points, and further accelerate the update and iteration
of ultrasound products.
In terms of the domestic market, the company will focus on the POC field and ultrasound department
.
Specifically, for the POC field, the company will combine the advantages of multiple product lines to further enhance the market share of portable ultrasound in POC application scenarios such as acute and severe diseases, anesthesia, and pain; For the ultrasound department, the ultrasound product category will be enriched by combining clinical pain points to further enhance the comprehensive competitiveness of ultrasound products
.
At present, Lipon's ultrasound products have covered more than 300 large tertiary hospitals
across the country.
In terms of overseas markets, the company will pay more attention to the localization construction of important overseas markets, further improve the after-sales service level of local users by introducing localized sales and operation teams, and lay out a global localized closed-loop ecological chain
.